Cargando…
Co Treatment With Biologic Agents and Immunotherapy in the Setting of irAEs of Difficult Management
In recent years, immunotherapy has become an important pillar of cancer treatment, with high response rates regardless of tumor histology or baseline mutations, sometime in patients without any alternative of treatment. Moreover, these treatments are moving from later line therapies to front-line th...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279607/ https://www.ncbi.nlm.nih.gov/pubmed/35847803 http://dx.doi.org/10.3389/fmed.2022.906098 |